Cwm LLC Has $961,000 Stock Position in ARK Genomic Revolution ETF (BATS:ARKG)

Cwm LLC lessened its stake in shares of ARK Genomic Revolution ETF (BATS:ARKG) by 22.2% during the third quarter, Holdings Channel.com reports. The firm owned 37,534 shares of the company’s stock after selling 10,726 shares during the period. Cwm LLC’s holdings in ARK Genomic Revolution ETF were worth $961,000 as of its most recent SEC filing.

Other large investors also recently made changes to their positions in the company. Main Management ETF Advisors LLC boosted its holdings in ARK Genomic Revolution ETF by 2.3% in the second quarter. Main Management ETF Advisors LLC now owns 2,754,610 shares of the company’s stock worth $64,678,000 after acquiring an additional 62,470 shares in the last quarter. BNP Paribas Financial Markets raised its position in shares of ARK Genomic Revolution ETF by 101.5% during the first quarter. BNP Paribas Financial Markets now owns 2,330,573 shares of the company’s stock worth $67,027,000 after purchasing an additional 1,173,872 shares during the period. Goldman Sachs Group Inc. lifted its holdings in shares of ARK Genomic Revolution ETF by 271.4% in the 4th quarter. Goldman Sachs Group Inc. now owns 642,800 shares of the company’s stock worth $21,090,000 after purchasing an additional 469,740 shares in the last quarter. Clearwater Capital Advisors LLC lifted its holdings in shares of ARK Genomic Revolution ETF by 3.8% in the 1st quarter. Clearwater Capital Advisors LLC now owns 173,759 shares of the company’s stock worth $4,997,000 after purchasing an additional 6,385 shares in the last quarter. Finally, Northwestern Mutual Wealth Management Co. grew its position in ARK Genomic Revolution ETF by 2.1% in the 2nd quarter. Northwestern Mutual Wealth Management Co. now owns 166,281 shares of the company’s stock valued at $3,904,000 after purchasing an additional 3,341 shares during the period.

ARK Genomic Revolution ETF Stock Performance

ARKG opened at $24.33 on Friday. The business’s fifty day simple moving average is $25.44 and its two-hundred day simple moving average is $25.28.

About ARK Genomic Revolution ETF

The ARK Genomic Revolution ETF (ARKG) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund is an actively managed fund that targets companies involved in the genomics industry. ARKG was launched on Oct 31, 2014 and is managed by ARK.